Literature DB >> 30449685

Ectonucleoside Triphosphate Diphosphohydrolase-3 Antibody Targets Adult Human Pancreatic β Cells for In Vitro and In Vivo Analysis.

Diane C Saunders1, Marcela Brissova2, Neil Phillips2, Shristi Shrestha3, John T Walker1, Radhika Aramandla2, Greg Poffenberger2, David K Flaherty4, Kevin P Weller4, Julie Pelletier5, Tracy Cooper6, Matt T Goff6, John Virostko7, Alena Shostak2, E Danielle Dean2, Dale L Greiner8, Leonard D Shultz9, Nripesh Prasad3, Shawn E Levy3, Robert H Carnahan10, Chunhua Dai2, Jean Sévigny11, Alvin C Powers12.   

Abstract

Identification of cell-surface markers specific to human pancreatic β cells would allow in vivo analysis and imaging. Here we introduce a biomarker, ectonucleoside triphosphate diphosphohydrolase-3 (NTPDase3), that is expressed on the cell surface of essentially all adult human β cells, including those from individuals with type 1 or type 2 diabetes. NTPDase3 is expressed dynamically during postnatal human pancreas development, appearing first in acinar cells at birth, but several months later its expression declines in acinar cells while concurrently emerging in islet β cells. Given its specificity and membrane localization, we utilized an NTPDase3 antibody for purification of live human β cells as confirmed by transcriptional profiling, and, in addition, for in vivo imaging of transplanted human β cells. Thus, NTPDase3 is a cell-surface biomarker of adult human β cells, and the antibody directed to this protein should be a useful new reagent for β cell sorting, in vivo imaging, and targeting.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  development; diabetes; glucagon; imaging; insulin; islet; pancreas

Mesh:

Substances:

Year:  2018        PMID: 30449685      PMCID: PMC6402969          DOI: 10.1016/j.cmet.2018.10.007

Source DB:  PubMed          Journal:  Cell Metab        ISSN: 1550-4131            Impact factor:   27.287


  44 in total

1.  Noninvasive in vivo imaging of pancreatic islet cell biology.

Authors:  Stephan Speier; Daniel Nyqvist; Over Cabrera; Jia Yu; R Damaris Molano; Antonello Pileggi; Tilo Moede; Martin Köhler; Johannes Wilbertz; Barbara Leibiger; Camillo Ricordi; Ingo B Leibiger; Alejandro Caicedo; Per-Olof Berggren
Journal:  Nat Med       Date:  2008-03-07       Impact factor: 53.440

2.  Epigenomic plasticity enables human pancreatic α to β cell reprogramming.

Authors:  Nuria C Bramswig; Logan J Everett; Jonathan Schug; Craig Dorrell; Chengyang Liu; Yanping Luo; Philip R Streeter; Ali Naji; Markus Grompe; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

Review 3.  Futility of attempts to detect and quantify beta cells by PET imaging in the pancreas: why it is time to abandon the approach.

Authors:  Abass Alavi; Thomas J Werner
Journal:  Diabetologia       Date:  2018-06-29       Impact factor: 10.122

Review 4.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

5.  Changes in expression of P2 receptors in rat and mouse pancreas during development and ageing.

Authors:  R Coutinho-Silva; M Parsons; T Robson; G Burnstock
Journal:  Cell Tissue Res       Date:  2001-10-10       Impact factor: 5.249

6.  Proliferation of sorted human and rat beta cells.

Authors:  G Parnaud; D Bosco; T Berney; F Pattou; J Kerr-Conte; M Y Donath; C Bruun; T Mandrup-Poulsen; N Billestrup; P A Halban
Journal:  Diabetologia       Date:  2007-11-10       Impact factor: 10.122

Review 7.  CD39 and CD73 in immunity and inflammation.

Authors:  Luca Antonioli; Pál Pacher; E Sylvester Vizi; György Haskó
Journal:  Trends Mol Med       Date:  2013-04-17       Impact factor: 11.951

8.  Electrophysiological and immunocytochemical evidence for P2X purinergic receptors in pancreatic beta cells.

Authors:  Amélia M Silva; Ricardo J Rodrigues; Angelo R Tomé; Rodrigo A Cunha; Stanley Misler; Luís M Rosário; Rosa M Santos
Journal:  Pancreas       Date:  2008-04       Impact factor: 3.327

9.  Characterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3 : partial characterization of the inhibitory epitope and potential applications.

Authors:  Mercedes N Munkonda; Julie Pelletier; Vasily V Ivanenkov; Michel Fausther; Alain Tremblay; Beat Künzli; Terence L Kirley; Jean Sévigny
Journal:  FEBS J       Date:  2009-01       Impact factor: 5.542

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  27 in total

1.  Human islets expressing HNF1A variant have defective β cell transcriptional regulatory networks.

Authors:  Rachana Haliyur; Xin Tong; May Sanyoura; Shristi Shrestha; Jill Lindner; Diane C Saunders; Radhika Aramandla; Greg Poffenberger; Sambra D Redick; Rita Bottino; Nripesh Prasad; Shawn E Levy; Raymond D Blind; David M Harlan; Louis H Philipson; Roland W Stein; Marcela Brissova; Alvin C Powers
Journal:  J Clin Invest       Date:  2018-12-03       Impact factor: 14.808

2.  PAM haploinsufficiency does not accelerate the development of diet- and human IAPP-induced diabetes in mice.

Authors:  Yi-Chun Chen; Richard E Mains; Betty A Eipper; Brad G Hoffman; Traci A Czyzyk; John E Pintar; C Bruce Verchere
Journal:  Diabetologia       Date:  2020-01-27       Impact factor: 10.122

3.  Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates.

Authors:  Siming Liu; Mikako Harata; Joseph A Promes; Anthony J Burand; James A Ankrum; Yumi Imai
Journal:  J Vis Exp       Date:  2019-05-14       Impact factor: 1.355

Review 4.  NIH Initiative to Improve Understanding of the Pancreas, Islet, and Autoimmunity in Type 1 Diabetes: The Human Pancreas Analysis Program (HPAP).

Authors:  Klaus H Kaestner; Alvin C Powers; Ali Naji; Mark A Atkinson
Journal:  Diabetes       Date:  2019-05-24       Impact factor: 9.461

Review 5.  Engineering islets from stem cells for advanced therapies of diabetes.

Authors:  Johanna Siehler; Anna Karolina Blöchinger; Matthias Meier; Heiko Lickert
Journal:  Nat Rev Drug Discov       Date:  2021-08-10       Impact factor: 84.694

Review 6.  The physiological role of β-cell heterogeneity in pancreatic islet function.

Authors:  Richard K P Benninger; Vira Kravets
Journal:  Nat Rev Endocrinol       Date:  2021-10-19       Impact factor: 43.330

7.  Integrated human pseudoislet system and microfluidic platform demonstrate differences in GPCR signaling in islet cells.

Authors:  John T Walker; Rachana Haliyur; Heather A Nelson; Matthew Ishahak; Gregory Poffenberger; Radhika Aramandla; Conrad Reihsmann; Joseph R Luchsinger; Diane C Saunders; Peng Wang; Adolfo Garcia-Ocaña; Rita Bottino; Ashutosh Agarwal; Alvin C Powers; Marcela Brissova
Journal:  JCI Insight       Date:  2020-05-21

8.  Global deletion of NTPDase3 protects against diet-induced obesity by increasing basal energy metabolism.

Authors:  Bynvant Sandhu; Maria C Perez-Matos; Stephanie Tran; Garima Singhal; Ismail Syed; Linda Feldbrügge; Shuji Mitsuhashi; Julie Pelletier; Jinhe Huang; Yusuf Yalcin; Eva Csizmadia; Shilpa Tiwari-Heckler; Keiichi Enjyoji; Jean Sévigny; Eleftheria Maratos-Flier; Simon C Robson; Z Gordon Jiang
Journal:  Metabolism       Date:  2021-02-23       Impact factor: 8.694

Review 9.  The Eye as a Transplantation Site to Monitor Pancreatic Islet Cell Plasticity.

Authors:  Erwin Ilegems; Per-Olof Berggren
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

10.  Generation of highly potent DYRK1A-dependent inducers of human β-Cell replication via Multi-Dimensional compound optimization.

Authors:  Paul A Allegretti; Timothy M Horton; Yassan Abdolazimi; Hannah P Moeller; Benjamin Yeh; Matthew Caffet; Guillermina Michel; Mark Smith; Justin P Annes
Journal:  Bioorg Med Chem       Date:  2019-11-11       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.